Results 101 to 110 of about 444,660 (199)

MORPHOLOGICAL FEATURES OF CONSTRICTIVE PERICARDITIS

open access: yesРоссийский кардиологический журнал, 2010
The features of pericardial morphology in constrictive pericarditis are described, based on the surgery material, which was obtained from 27 patients aged 5-77 years during pericardectomy.
V. V. Kochmasheva   +2 more
doaj  

Idiopathic recurrent pericarditis refractory to colchicine treatment can reveal tumor necrosis factor receptor-associated periodic syndrome [PDF]

open access: yes, 2009
Recurrences develop in up to 20-50% of patients with acute pericarditis. Although different causes of recurrent pericarditis have been identified, the etiology remains obscure in most cases which are therefore labelled as idiopathic.
LAGHI PASINI F.   +18 more
core   +1 more source

Role of Cardiac MRI and CT in Pericarditis and Pericardial Constriction

open access: yesMethodist DeBakey Cardiovascular Journal
Pericardial diseases span a spectrum from acute and recurrent pericarditis to chronic constrictive pericarditis. While echocardiography remains the first-line test in the evaluation of patients with suspected pericardial disease, advanced cardiac imaging
Kazim Baser   +6 more
doaj   +1 more source

Unraveling Heart Inflammation: Recurrent Myopericarditis Caused by Coxsackie A Virus—A Case Report

open access: yesClinical Case Reports
Acute recurrent myopericarditis, characterized by the occurrence of a new myopericarditis event following a symptom‐free interval of 4–6 weeks, is relatively rare lacking definitive guidelines for management.
Maisha Maliha   +8 more
doaj   +1 more source

Recurrent pericarditis in children and adolescents: a large multicentric case-series and implications for the pediatric rheumatologist

open access: yes, 2013
RECURRENT PERICARDITIS IN CHILDREN AND ADOLESCENTS: A LARGE, MULTICENTRIC CASE-SERIES AND IMPLICATIONS FOR THE PEDIATRIC ...
Gattorno M   +10 more
core   +1 more source

Recurrent pericarditis: the importance of guideline-based treatment for reducing recurrences. A single centre experience.

open access: yes
reservedIntroduction: Acute pericarditis, while generally considered a benign disease, may relapse in a sizable proportion of cases. Although innovative therapies, such as anti-IL1 drugs, have emerged as promising treatment options, the criteria for ...
BOCAJ, IRIS
core  

P118 | Long term outcome and disease duration in patients treated with anti-IL 1 drugs for recurrent pericarditis: ad interim analysis of a longitudinal study

open access: yesItalian Journal of Medicine
Background: Although anti-IL 1 drugs have been proven effective in treating recurrent pericarditis, there is a lack of data about their long-term follow-up. Objectives: To evaluate the percentage of patients with recurrent pericarditis treated with anti-
doaj   +1 more source

Sustained Pericarditis Recurrence Risk Reduction With Long‐Term Rilonacept

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Rilonacept, a once‐weekly interleukin‐1 alpha and beta cytokine trap, reduced pericarditis recurrence in the phase 3 study, RHAPSODY (Rilonacept Inhibition of Interleukin‐1 Alpha and Beta for Recurrent Pericarditis: A Pivotal Symptomatology ...
Massimo Imazio   +17 more
doaj   +1 more source

Immunosuppressive therapy prevents development of recurrent pericarditis

open access: yes, 1995
OBJECTIVES: This study reviews the clinical outcome of a series of patients with recurrent pericarditis before and after immunosuppressive therapy.
LAVEDER F   +5 more
core  

Corticosteroids for Acute and Recurrent Idiopathic Pericarditis: Unexpected Evidences

open access: yesCardiology Research and Practice, 2019
Pericarditis is a common disease, often postviral or “idiopathic,” diagnosed in about 5% of emergency room visits for non-ischemic chest pain. Although pericarditis often occurs as a benign and self-limiting disease, it may present recurrences. The first-
Antonio Perrone   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy